COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
The aim: to reflect the features of the course of irritable bowel syndrome during the COVID-19 pandemic.Key points. It has been noted that the COVID-19 may contribute to the formation of post-infectious functional gastrointestinal diseases, given that angiotensin-converting enzyme-2 (ACE-2) receptor...
Main Author: | V. A. Akhmedov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2022-08-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/664 |
Similar Items
-
Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome
by: V V Tsukanov, et al.
Published: (2016-08-01) -
Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01) -
The role of probiotics in current algorithms for the treatment of irritable bowel syndrome: A review
by: Dmitry N. Andreev, et al.
Published: (2023-08-01) -
Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
by: Alessandra Lo Presti, et al.
Published: (2019-07-01) -
Irritable Bowel Syndrome: Role of Intestinal Microbiota Disorders and Ways of Their Correction
by: I.Ya. Budzak
Published: (2013-09-01)